STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

BIOTECHNOLOGY INNOVATION ORGANIZATION: Form 990, tax year 2018

View the entire original 990 at ProPublica ↗

Organization
BIOTECHNOLOGY INNOVATION ORGANIZATION (EIN 52-1224577)
Tax period
2018-01-01 to 2018-12-31
Filed
2019-11-15
IRS object ID
201933199349319758
Schema version
2018v3.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2019-11-15T14:23:39-06:00ReturnTs
Tax Period End2018-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN410746749PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CLIFTONLARSONALLEN LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1901 N GLEBE ROAD SUITE 200AddressLine1Txt
CityARLINGTONCityNm
State AbbreviationVAStateAbbreviationCd
ZIP22203ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2018-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN521224577EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1BIOTECHNOLOGY INNOVATION ORGANIZATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlBIOTBusinessNameControlTxt
Phone2029629200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW NO 900AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonYVETTE WHITE-WIGGINSPersonNm
Person TitleCFO AND SVP, FINANCE & ADMINPersonTitleTxt
Phone2029629200PhoneNum
Signature2019-11-15SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonAMY CHAPMANPreparerPersonNm
PTINP00843460PTIN
Phone5712279500PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address67.137.57.251IPv4AddressTxt
FieldValueIRS element (for citing)
IP2019-11-15IPDt
IP Tm15:22:47IPTm
IP TimezoneESIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device Id3F26782FE4A8D097B8E6D44DA42E2066FBD559CCAtSubmissionCreationDeviceId
At Submission Filing Device Id2133D0EBAFB53FCF2392F5AD4E899C8767C52AD0AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2018TaxYr
Build TS2020-04-17 16:48:07ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJAMES C GREENWOODPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW NO 900AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$87,471,231GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501cYes (X)Organization501cInd
Website AddressWWW.BIO.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1993FormationYr
Legal Domicile StateDCLegalDomicileStateCd
Activity Or MissionSUPPORT THE BIOTECHNOLOGY INDUSTRY TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND.ActivityOrMissionDesc
Voting Members Governing Body138VotingMembersGoverningBodyCnt
Voting Members Independent138VotingMembersIndependentCnt
Total Employee218TotalEmployeeCnt
Total Volunteers148TotalVolunteersCnt
Total Gross UBI$693,008TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$0PYContributionsGrantsAmt
CY Contributions Grants$0CYContributionsGrantsAmt
PY Program Service Revenue$66,032,153PYProgramServiceRevenueAmt
CY Program Service Revenue$72,848,062CYProgramServiceRevenueAmt
PY Investment Income$2,716,705PYInvestmentIncomeAmt
CY Investment Income$2,538,802CYInvestmentIncomeAmt
PY Other Revenue$9,803,104PYOtherRevenueAmt
CY Other Revenue$11,923,567CYOtherRevenueAmt
PY Total Revenue$78,551,962PYTotalRevenueAmt
CY Total Revenue$87,310,431CYTotalRevenueAmt
PY Grants And Similar Paid$785,500PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$2,626,800CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$34,575,243PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$36,867,200CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$42,956,281PYOtherExpensesAmt
CY Other Expenses$47,030,501CYOtherExpensesAmt
PY Total Expenses$78,317,024PYTotalExpensesAmt
CY Total Expenses$86,524,501CYTotalExpensesAmt
PY Revenues Less Expenses$234,938PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$785,930CYRevenuesLessExpensesAmt
Total Assets BOY$81,025,145TotalAssetsBOYAmt
Total Assets EOY$78,940,053TotalAssetsEOYAmt
Total Liabilities BOY$34,368,598TotalLiabilitiesBOYAmt
Total Liabilities EOY$36,968,656TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$46,656,547NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$41,971,397NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
DescADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2017 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT BIOETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2018 ADVOCACY ACCOMPLISHMENTS: - PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.THE EMERGING COMPANIES SECTION 2018 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES IN THE TAX REFORM DEBATE.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.THE FOOD & AGRICULTURE SECTION 2018 ADVOCACY ACCOMPLISHMENTS: - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS FOR AG-BIOTECH PRODUCTS. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN TO ADDRESS TRADE ISSUES IN AGRICULTURAL EXPORT MARKETS SUCH AS CHINA AND EUROPE. - ADVOCATED IN LEGISLATURES AND COURTS TO PRESERVE THE RIGHTS OF FARMERS TO PLANT GENETICALLY ENGINEERED CROPS. THE INDUSTRIAL & ENVIRONMENTAL SECTION 2018 ADVOCACY ACCOMPLISHMENTS: - SUPPORTED A RENEWABLE CHEMICALS REPORT.- ADVOCATED FOR EPA TO TREAT ALL SUSTAINABLY SOURCED BIOMASS AS ELIGIBLE MEASURES FOR EMISSIONS REDUCTION CREDIT (ERC) GENERATION. - ADVOCATED REGARDING THE IMPLEMENTATION OF THE TOXIC SUBSTANCES CONTROL ACT (TSCA) AS AMENDED BY CONGRESS, AS WELL AS ISSUES RELATING TO THE NATIONAL BIOENGINEERED FOOD DISCLOSURE ACT.- ENGAGED WITH THE ADMINISTRATION'S REVIEW OF THE COORDINATED FRAMEWORK FOR BIOTECHNOLOGY, INCLUDING WITH RESPECT TO THE REGULATION OF GENETICALLY ENGINEERED (GE) ALGAE.- URGED CONGRESS TO EXTEND A SUITE OF CRITICAL ADVANCED BIOFUELS TAX INCENTIVES BEYOND 2017.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
DescSERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY STAKEHOLDERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES. THE BIO INTERNATIONAL CONVENTION ATTRACTS APPROXIMATELY 16,000 OF THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 76 COUNTRIES AND 48 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA, PUERTO RICO AND THE US VIRGIN ISLANDS, INCLUDING 300 MEMBERS OF THE MEDIA, AND OFFERS THREE DAYS OF PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES. THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. THE BIO BUSINESS FORUM AT THE CONVENTION HOSTS TENS OF THOUSANDS OF PARTNERING MEETINGS AMONG A FEW THOUSAND COMPANIES, ALONG WITH A COUPLE HUNDRED COMPANY PRESENTATIONS. THE CONVENTION HOSTS HUNDREDS OF SPEAKERS, AND OVER A THOUSAND EXHIBITIONS WITH INTERNATIONAL, REGIONAL AND STATE PAVILIONS (AND A NUMBER OF PRODUCT FOCUS ZONES).BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS.Desc
FieldValueIRS element (for citing)
Described In Section501c30DescribedInSection501c3Ind
Schedule B Required0ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Subject To Proxy TaxYes (1)SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam MemYes (1)BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document177IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee218EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Foreign Financial AccountYes (1)ForeignFinancialAccountInd
Foreign CountryINForeignCountryCd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtYes (1)SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members138GoverningBodyVotingMembersCnt
Independent Voting Member138IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn Body0Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonYVETTE WHITE-WIGGINSPersonNm
Phone2029629200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW SUITE 990AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (147 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
JOHN MARAGANORE
CHAIR2.00Yes (X)Yes (X)$0$0$0
RON COHEN
IMMEDIATE PAST CHAIR2.00Yes (X)Yes (X)$0$0$0
BRADFORD ZAKES
TREASURER2.00Yes (X)Yes (X)$0$0$0
JULIE GERBERDING
SECRETARY2.00Yes (X)Yes (X)$0$0$0
ABBIE CELNIKER
DIRECTOR2.00Yes (X)$0$0$0
ADAM MONROE
DIRECTOR2.00Yes (X)$0$0$0
ADELENE PERKINS
DIRECTOR2.00Yes (X)$0$0$0
ALAN SHAW
DIRECTOR2.00Yes (X)$0$0$0
ALBERT BOURLA
DIRECTOR2.00Yes (X)$0$0$0
AMIR NASHAT
DIRECTOR2.00Yes (X)$0$0$0
ANNA PROTOPAPAS
DIRECTOR2.00Yes (X)$0$0$0
ANNA RATH
DIRECTOR2.00Yes (X)$0$0$0
ANNE PHILLIPS
DIRECTOR2.00Yes (X)$0$0$0
BARRY FLANNELLY
DIRECTOR2.00Yes (X)$0$0$0
BASSIL DAHIYAT
DIRECTOR2.00Yes (X)$0$0$0
BENJAMIN KNUDSEN
DIRECTOR2.00Yes (X)$0$0$0
BILL ANDERSON
DIRECTOR2.00Yes (X)$0$0$0
BILL CAMPBELL
DIRECTOR2.00Yes (X)$0$0$0
BILL SIBOLD
DIRECTOR2.00Yes (X)$0$0$0
BOB MORE
DIRECTOR2.00Yes (X)$0$0$0
BOB WALSH
DIRECTOR2.00Yes (X)$0$0$0
BRIAN PEREIRA
DIRECTOR2.00Yes (X)$0$0$0
BRIAN THOME
DIRECTOR2.00Yes (X)$0$0$0
CARLOS PAYA
DIRECTOR2.00Yes (X)$0$0$0
CARSTEN BRUNN
DIRECTOR2.00Yes (X)$0$0$0
CEDRIC FRANCOIS
DIRECTOR2.00Yes (X)$0$0$0
CHARL VAN ZYL
DIRECTOR2.00Yes (X)$0$0$0
CHRIS STANDLEE
DIRECTOR2.00Yes (X)$0$0$0
CHRISTI SHAW
DIRECTOR2.00Yes (X)$0$0$0
CHRISTOPHE SCHILLING
DIRECTOR2.00Yes (X)$0$0$0
CHRISTOPHER HEALEY
DIRECTOR2.00Yes (X)$0$0$0
CLIVE MEANWELL
DIRECTOR2.00Yes (X)$0$0$0
DAN MEAGHER
DIRECTOR2.00Yes (X)$0$0$0
DAPHNE PREUSS
DIRECTOR2.00Yes (X)$0$0$0
DAVID KETTNER
DIRECTOR2.00Yes (X)$0$0$0
DAVID MAIN
DIRECTOR2.00Yes (X)$0$0$0
DAVID NICHOLSON
DIRECTOR2.00Yes (X)$0$0$0
DAVID STACK
DIRECTOR2.00Yes (X)$0$0$0
DEBORAH DUNSIRE
DIRECTOR2.00Yes (X)$0$0$0
DOUG BERVEN
DIRECTOR2.00Yes (X)$0$0$0
DOUGLAS DOERFLER
DIRECTOR2.00Yes (X)$0$0$0
EDDIE SULLIVAN
DIRECTOR2.00Yes (X)$0$0$0
ELIZABETH LEWIS
DIRECTOR2.00Yes (X)$0$0$0
ERIKA SMITH
DIRECTOR2.00Yes (X)$0$0$0
FABRICE CHOURAQUI
DIRECTOR2.00Yes (X)$0$0$0
FRANK TERHORST
DIRECTOR2.00Yes (X)$0$0$0
GARY ZIEZIULA
DIRECTOR2.00Yes (X)$0$0$0
GEORGE SCANGOS
DIRECTOR2.00Yes (X)$0$0$0
GIL VAN BOKKELEN
DIRECTOR2.00Yes (X)$0$0$0
GREGG ALTON
DIRECTOR2.00Yes (X)$0$0$0
H THOMAS WATKINS
DIRECTOR2.00Yes (X)$0$0$0
HELEN TORLEY
DIRECTOR2.00Yes (X)$0$0$0
HERVE HOPPENOT
DIRECTOR2.00Yes (X)$0$0$0
HOWARD ROBIN
DIRECTOR2.00Yes (X)$0$0$0
HUGH WELSH
DIRECTOR2.00Yes (X)$0$0$0
JAMES SAPIRSTEIN
DIRECTOR2.00Yes (X)$0$0$0
JAMES SULLIVAN
DIRECTOR2.00Yes (X)$0$0$0
JEAN-CHRISTOPHE TELLIER
DIRECTOR2.00Yes (X)$0$0$0
JEAN-JACQUES BIENAIME
DIRECTOR2.00Yes (X)$0$0$0
JEFF KINDLER
DIRECTOR2.00Yes (X)$0$0$0
JEFFREY CLELAND
DIRECTOR2.00Yes (X)$0$0$0
JEFFREY MARRAZZO
DIRECTOR2.00Yes (X)$0$0$0
JENNIFER HOLMGREN
DIRECTOR2.00Yes (X)$0$0$0
JENNIFER TAUBERT
DIRECTOR2.00Yes (X)$0$0$0
JEREMY LEVIN
DIRECTOR2.00Yes (X)$0$0$0
JERRY FLINT
DIRECTOR2.00Yes (X)$0$0$0
JILL ZULLO
DIRECTOR2.00Yes (X)$0$0$0
JIM MEYERS
DIRECTOR2.00Yes (X)$0$0$0
JOEL MARCUS
DIRECTOR2.00Yes (X)$0$0$0
JOHN CROWLEY
DIRECTOR2.00Yes (X)$0$0$0
JOHN LEPORE
DIRECTOR2.00Yes (X)$0$0$0
JOHN MELO
DIRECTOR2.00Yes (X)$0$0$0
JOHN SWART
DIRECTOR2.00Yes (X)$0$0$0
JOHN YOUNG
DIRECTOR2.00Yes (X)$0$0$0
JOSEPH LAROSA
DIRECTOR2.00Yes (X)$0$0$0
JOSHUA OFMAN
DIRECTOR2.00Yes (X)$0$0$0
JULIA OWENS
DIRECTOR2.00Yes (X)$0$0$0
JUSTIN GOVER
DIRECTOR2.00Yes (X)$0$0$0
KARSTEN TEMME
DIRECTOR2.00Yes (X)$0$0$0
KATRINE BOSLEY
DIRECTOR2.00Yes (X)$0$0$0
KENNETH MOCH
DIRECTOR2.00Yes (X)$0$0$0
KEVIN GORMAN
DIRECTOR2.00Yes (X)$0$0$0
KIRAN MAZUMDAR-SHAW
DIRECTOR2.00Yes (X)$0$0$0
LAURA BEREZIN
DIRECTOR2.00Yes (X)$0$0$0
LONNIE MOULDER
DIRECTOR2.00Yes (X)$0$0$0
MARK DROZDOWSKI
DIRECTOR2.00Yes (X)$0$0$0
MARK ENYEDY
DIRECTOR2.00Yes (X)$0$0$0
MARK JONES
DIRECTOR2.00Yes (X)$0$0$0
MARK PRUZANSKI
DIRECTOR2.00Yes (X)$0$0$0
MARK SKALETSKY
DIRECTOR2.00Yes (X)$0$0$0
MARK TRUDEAU
DIRECTOR2.00Yes (X)$0$0$0
MARTIN BABLER
DIRECTOR2.00Yes (X)$0$0$0
MAXINE GOWEN
DIRECTOR2.00Yes (X)$0$0$0
MICHAEL MORRISSEY
DIRECTOR2.00Yes (X)$0$0$0
MICHAEL NARACHI
DIRECTOR2.00Yes (X)$0$0$0
MICHAEL RAAB
DIRECTOR2.00Yes (X)$0$0$0
MICHAEL RYAN
DIRECTOR2.00Yes (X)$0$0$0
NANCY SIMONIAN
DIRECTOR2.00Yes (X)$0$0$0
NICK LESCHLY
DIRECTOR2.00Yes (X)$0$0$0
OLIVER WALKER
DIRECTOR2.00Yes (X)$0$0$0
PAIGE MAHANEY
DIRECTOR2.00Yes (X)$0$0$0
PAT GRUBER
DIRECTOR2.00Yes (X)$0$0$0
PAUL BACKMAN
DIRECTOR2.00Yes (X)$0$0$0
PAUL HASTINGS
DIRECTOR2.00Yes (X)$0$0$0
PAUL MCKENZIE
DIRECTOR2.00Yes (X)$0$0$0
PERRY STERNBERG
DIRECTOR2.00Yes (X)$0$0$0
PETER GREENLEAF
DIRECTOR2.00Yes (X)$0$0$0
PHILIP MILLER
DIRECTOR2.00Yes (X)$0$0$0
RACHEL KING
DIRECTOR2.00Yes (X)$0$0$0
RICHARD POPS
DIRECTOR2.00Yes (X)$0$0$0
RICK WINNINGHAM
DIRECTOR2.00Yes (X)$0$0$0
ROBERT WILLS
DIRECTOR2.00Yes (X)$0$0$0
ROGER WYSE
DIRECTOR2.00Yes (X)$0$0$0
RONALD STOTISH
DIRECTOR2.00Yes (X)$0$0$0
RUSSELL HERNDON
DIRECTOR2.00Yes (X)$0$0$0
SABINE LUIK
DIRECTOR2.00Yes (X)$0$0$0
SANDY MACRAE
DIRECTOR2.00Yes (X)$0$0$0
SARAH HULL
DIRECTOR2.00Yes (X)$0$0$0
SCOTT GARLAND
DIRECTOR2.00Yes (X)$0$0$0
SCOTT HOLMSTROM
DIRECTOR2.00Yes (X)$0$0$0
SCOTT KOENIG
DIRECTOR2.00Yes (X)$0$0$0
SCOTT SMITH
DIRECTOR2.00Yes (X)$0$0$0
SHAJI PROCIDA
DIRECTOR2.00Yes (X)$0$0$0
SHARON MATES
DIRECTOR2.00Yes (X)$0$0$0
SIMON WADDINGTON
DIRECTOR2.00Yes (X)$0$0$0
STEVEN MENTO
DIRECTOR2.00Yes (X)$0$0$0
STEVEN PAUL
DIRECTOR2.00Yes (X)$0$0$0
STUART ARBUCKLE
DIRECTOR2.00Yes (X)$0$0$0
SUE WASHER
DIRECTOR2.00Yes (X)$0$0$0
TAMMY LEE
DIRECTOR2.00Yes (X)$0$0$0
TED LOVE
DIRECTOR2.00Yes (X)$0$0$0
TERRIE CURRAN
DIRECTOR2.00Yes (X)$0$0$0
THOMAS WIGGANS
DIRECTOR2.00Yes (X)$0$0$0
TIMOTHY WALBERT
DIRECTOR2.00Yes (X)$0$0$0
TJERK DE RUITER
DIRECTOR2.00Yes (X)$0$0$0
VINCENT SEWALT
DIRECTOR2.00Yes (X)$0$0$0
WILLIAM FITZSIMMONS
DIRECTOR2.00Yes (X)$0$0$0
WILLIAM NEWELL
DIRECTOR2.00Yes (X)$0$0$0
JAMES GREENWOOD
PRESIDENT & CHIEF EXECUTIVE OFFICER40.00Yes (X)$2,578,863$0$150,227
YVETTE WHITE-WIGGINS
SVP & CHIEF FINANCIAL OFFICER40.00Yes (X)$425,637$0$71,878
THOMAS DILENGE
PRESIDENT, ADVOCACY/LAW/PUBLIC POLIC40.00$707,288$0$72,513Yes (X)
JOANNE DUNCAN
PRESIDENT, MEMBERSHIP & BUS OPER DIV40.00$707,288$0$67,859Yes (X)
DANIEL DURHAM
EVP, HEALTH POLICY40.00$602,454$0$70,268Yes (X)
BRENT ERICKSON
EVP, INDUSTRIAL & ENVIRONMENT40.00$517,982$0$56,118Yes (X)
JOSEPH DAMOND
SVP, INTERNATIONAL AFFAIRS40.00$486,197$0$73,068Yes (X)
JEANNE HAGGERTY
EVP, GOVERMENT AFFAIRS & EXTERNAL RELATIONS40.00$481,261$0$46,953Yes (X)
ELIZABETH ESHAM
EVP, ECS & VP, SCIENCE & REGULATORY40.00$461,023$0$51,784Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$6,967,993TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$660,668TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K99IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
FREEMAN EXPOSITIONS
PO BOX 660613DALLASTX75266CONVENTION & CONFERENCES CONTRACTOR$2,774,625
LEVY RESTAURANTS FOOD SERVICE
415 SUMMER STREETBOSTONMA02210CATERING$1,250,718
PROJECTION INC
PO BOX 890472CHARLOTTENC28289AUDIO/VISUAL SERVICES$966,373
MASSACHUSETTS CONVENTION CENTER
415 SUMMER STREETBOSTONMA02210CONVENTION CENTER RENTAL$766,252
SUBJECT MATTER
1201 NEW YORK AVENUE NWWASHINGTONDC20005CONSULTING SERVICES$751,644
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K101CntrctRcvdGreaterThan100KCnt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
CONFERENCE/MEETING REVENUE541800$41,064,421$40,862,634$201,787
MEMBERSHIP DUES900099$29,904,703$29,904,703
EPF MEMBER SUPPORT900099$832,500$832,500
INTERNATIONAL EFFORTS900099$506,000$506,000
LEGAL & POLICY SUPPORT900099$405,438$405,438

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$135,000TotalRevenueColumnAmt
Related Or Exempt Func Income$135,000RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$72,848,062TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,539,768TotalRevenueColumnAmt
Exclusion$2,539,768ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$11,760,723TotalRevenueColumnAmt
Unrelated Business Revenue$471,221UnrelatedBusinessRevenueAmt
Exclusion$11,289,502ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$43,572RealAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$43,572RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$116,262SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$117,228SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$966SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$966TotalRevenueColumnAmt
Exclusion-$966ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
CBI900099$106,428$106,428
BIONEWS ADS INCOME541800$20,000$20,000

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$36,416TotalRevenueColumnAmt
Exclusion$36,416ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$162,844OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$87,310,431TotalRevenueColumnAmt
Related Or Exempt Func Income$72,752,703RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$693,008UnrelatedBusinessRevenueAmt
Exclusion$13,864,720ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$2,589,000TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$37,800TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$4,781,554TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$25,076,505TotalAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$2,143,270TotalAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$3,307,030TotalAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,558,841TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$200,471TotalAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$69,762TotalAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$3,730,312TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$53,443TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$9,391,095TotalAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$384,564TotalAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$761,242TotalAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$1,505,528TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$4,074,370TotalAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,978,810TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$17,046,500TotalAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$7,936TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$4,764,357TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$493,483TotalAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$126,371TotalAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmt
DUES & SUBSCRIPTIONS$1,312,273
OUTREACH$498,580
TAXES PAID$374,369
BIO LEGISLATIVE DAY/FLY$211,040

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$45,995TotalAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$86,524,501TotalAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$6,917,248BOYAmt
EOY$6,430,187EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$3,265,043BOYAmt
EOY$3,364,536EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$3,137,266BOYAmt
EOY$4,302,636EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$2,686,112BOYAmt
EOY$2,635,707EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$7,486,361LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$6,397,443LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$942,377BOYAmt
EOY$1,088,918EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$64,077,099BOYAmt
EOY$61,118,069EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$81,025,145BOYAmt
EOY$78,940,053EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$17,217,909BOYAmt
EOY$18,759,698EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$13,458,572BOYAmt
EOY$15,113,063EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$3,692,117BOYAmt
EOY$3,095,895EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$34,368,598BOYAmt
EOY$36,968,656EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$46,656,547BOYAmt
EOY$41,971,397EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$46,656,547BOYAmt
EOY$41,971,397EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$81,025,145BOYAmt
EOY$78,940,053EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$785,930ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$6,130,430NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$659,350OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Substantially All Dues Nonded0SubstantiallyAllDuesNondedInd
Only In House Lobbying0OnlyInHouseLobbyingInd
Agree Carryover Prior YearYes (1)AgreeCarryoverPriorYearInd
Dues Assessments$29,904,703DuesAssessmentsAmt
Non Deductible Lbbyng Pltcl CY$9,870,000NonDeductibleLbbyngPltclCYAmt
Non Ded Lbbyng Pltcl Cyov$261,880NonDedLbbyngPltclCyovAmt
Non Deductible Lbbyng Pltcl Tot$10,131,880NonDeductibleLbbyngPltclTotAmt
Aggregate Reported Dues Ntc$9,868,552AggregateReportedDuesNtcAmt
Carried Over$263,328CarriedOverAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$6,252,875OtherCostOrOtherBasisAmt
Depreciation$5,778,492DepreciationAmt
Book Value$474,383BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$276,745OtherCostOrOtherBasisAmt
Depreciation$149,307DepreciationAmt
Book Value$127,438BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$956,741OtherCostOrOtherBasisAmt
Depreciation$469,644DepreciationAmt
Book Value$487,097BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$1,088,918TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
CAPITAL LEASE OBLIGATION$130,657
DEFERRED RENT$2,965,238
FieldValueIRS element (for citing)
Total Liability$3,095,895TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$84,120,824TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$6,130,430NetUnrealizedGainsInvstAmt
Other Revenue$2,950,694OtherRevenueAmt
Revenue Not Reported-$3,179,736RevenueNotReportedAmt
Revenue Subtotal$87,300,560RevenueSubtotalAmt
Investment Expenses Not Incld$53,443InvestmentExpensesNotIncldAmt
Other Revenues Not Included-$43,572OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$9,871RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$87,310,431TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$88,805,974TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$2,374,916OtherExpensesIncludedAmt
Expenses Not Reported$2,374,916ExpensesNotReportedAmt
Expenses Subtotal$86,431,058ExpensesSubtotalAmt
Investment Expenses Not Incld2$53,443InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$40,000OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$93,443ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$86,524,501TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART XI, LINE 2D - OTHER ADJUSTMENTS:BIOSIMILARS REVENUE 119,103. FGR SPECIAL INITIATIVES REVENUE 392,198. CBI LOBBYING FUND 2,439,393.
PART XI, LINE 4B - OTHER ADJUSTMENTS:RENTAL EXPENSES -43,572.
PART XII, LINE 2D - OTHER ADJUSTMENTS:FOOD & AG LEGAL FUND EXPENSES BIOSIMILAR EXPENSES 119,103. FGR SPECIAL INITIATIVE EXPENSES 401,848. FOOD & AG SGR FUND 1,810,393. RENTAL EXPENSES 43,572.
PART XII, LINE 4B - OTHER ADJUSTMENTS:DEFERRED SPONSORSHIP EXPENSE 40,000.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA,03PROGRAM SERVICESCONFERENCES, ADVOCACY$569,391
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM02PROGRAM SERVICESCONFERENCES, ADVOCACY AND EDUCATION$250,915
MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT,01PROGRAM SERVICESADVOCACY$7,169
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES12PROGRAM SERVICESCONFERENCES, ADVOCACY$1,041,159
SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR,01PROGRAM SERVICESADVOCACY$107,554
SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL,00PROGRAM SERVICESADVOCACY$9,959
SUB-SAHARAN AFRICA00PROGRAM SERVICESADVOCACY$33,817
FieldValueIRS element (for citing)
Subtotal Offices1SubtotalOfficesCnt
Subtotal Employees9SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office1TotalOfficeCnt
Total Employee9TotalEmployeeCnt
Subtotal Spent$2,019,964SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$2,019,964TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (2 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmt
SOUTH AMERICASPONSORSHIP$25,000
SOUTH AMERICADONATION$12,800
FieldValueIRS element (for citing)
Total501c3 Org2Total501c3OrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationTHE ORGANIZATION HAS SUPPORTING DOCUMENTATION FOR THE AMOUNT THAT IS INVOICED FROM THE COMPANIES.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (63 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
ADAP ADVOCACY ASSOCIATION
131 E DAVIE STREET SUITE 201RALEIGHNC27601260482120501(C)(3)$6,000SCHOLARSHIP
AKIN GUMP STRAUSS HAUER & FELD LLP
1700 PACIFIC AVENUE SUITE 4100DALLASTX752014624751338644N/A$15,000CONTRIBUTION
ALLIANCE FOR AGING RESEARCH
1700 K STREET NW SUITE 740WASHINGTONDC20006541379174501(C)(3)$15,000SPONSORSHIP
ALLIANCE TO PROTECT MEDICAL INNOVATION
1220 L ST NW SUITE 100 488WASHINGTONDC20005831354631N/A$100,000CONTRIBUTION
AMERICAN AUTOIMMUNE RELATED DISEASES ASSOCIATION
22100 GRATIOT AVEEASTPOINTEMI480212227383027574501(C)(3)$10,000GENERAL SUPPORT
AMERICAN CANCER SOCIETY ACTION NETWORK INC
555 11TH STREET NW SUITE 300WASHINGTONDC20004522340031501(C)(4)$10,000SPONSORSHIP
AMERICAN ENTERPRISE INSTITUTE FOR PUBLIC POLICY RESEARCH
1789 MASSACHUSETTS AVENUE NWWASHINGTONDC20036530218495501(C)(3)$15,000GENERAL SUPPORT
ARIZONA BIOINDUSTRY ASSOCIATION INC
107 S SOUTHGATE DRIVECHANDLERAZ85226860938465501(C)(6)$15,000SPONSORSHIP
BIO NEBRASKA LIFE SCIENCES ASSOCIATION
PO BOX 24802OMAHANE68124202214508N/A$12,000SPONSORSHIP
BIO NJ
1255 WHITEHORSE-MERCERVILLE RDTRENTONNJ08619223284393N/A$10,000GENERAL SUPPORTBUILDING B - SUITE 514
BIO NJ
1255 WHITEHORSE-MERCERVILLE RDTRENTONNJ08619223284393N/A$60,000SPONSORSHIPBUILDING B - SUITE 514
BIOFLORIDA INC
6742 FOREST HILL BLVD SUITE 256WEST PALM BEACHFL33413593436638501(C)(6)$5,500SPONSORSHIP
BIOOHIO
1275 KINNEAR RDCOLUMBUSOH43212341577705501(C)(3)$12,000SPONSORSHIP
BIOUTAH
PO BOX 58531SALT LAKE CITYUT841580531900899204501(C)(6)$15,000GENERAL SUPPORT
CANCER SUPPORT COMMUNITY
734 15TH STREET NW SUITE 300WASHINGTONDC20005954163931501(C)(3)$20,000GENERAL SUPPORT
CENTER FOR MEDICINE IN THE PUBLIC INTEREST
757 THIRD AVENUE 20TH FLOORNEW YORKNY10017204321812501(C)(3)$25,000GENERAL SUPPORT
CHAMBER OF COMMERCE OF THE USA
1615 H STREET NWWASHINGTONDC20062530045720501(C)(6)$180,000GENERAL SUPPORT
COLORADO BIOSCIENCE ASSOCIATION
600 GRANT STREET SUITE 306DENVERCO80203841363258501(C)(6)$10,000SPONSORSHIP
CROPLIFE AMERICA
1156 15TH ATREET NW SUITE 400WASHINGTONDC20005530190293501(C)(6)$10,000SPONSORSHIP
CULTIVATING CHANGE FOUNDATION
965 GEARY ST 2SAN FRANCISCOCA94109810991258501(C)(3)$5,000SPONSORSHIP
CYSTIC FIBROSIS FOUNDATION
4550 MONTGOMERY AVENUE SUITE 1100BETHESDAMD20814131930701501(C)(3)$6,500SPONSORSHIP
DEMOCRATIC GOVERNORS ASSOCIATION
1225 EYE ST NW SUITE 1100WASHINGTONDC20005521304889N/A$25,000CONTRIBUTION
EVERYLIFE FOUNDATION FOR RARE DISEASES
1012 14TH ST NW SUITE 500WASHINGTONDC20005264614274501(C)(3)$10,000SPONSORSHIP
FARMERS ALLIANCE FOR INTEGRATED RESOURCES
1260 COUNTY ROAD 20 1/2LONGMONTCO80504454591729501(C)(5)$25,000GENERAL SUPPORT
FUELSAMERICA
607 FORT WILLIAMS PKWYALEXANDRIAVA22304460991009501(C)(4)$250,000GENERAL SUPPORT
GENETIC ALLIANCE
4301 CONNECTICUT AVENUE NW SUITEWASHINGTONDC200082304521571905501(C)(3)$10,000GENERAL SUPPORT404
GEORGE MASON UNIVERSITY FOUNDATION INC
4400 UNIVERSITY DRIVE MSN 1A3FAIRFAXVA22201541603842501(C)(3)$25,000DONATION
GLOBAL GENES
28 ARGONAUT SUITE 150ALISO VIEJOCA92656263331487501(C)(3)$15,000SPONSORSHIP
HAWAII CROP IMPROVEMENT ASSOCIATION
PO BOX 126AIEAHI96701990258882501(C)(6)$574,000GENERAL SUPPORT
HAWAII FARM BUREAU FEDERATION
PO BOX 253KUNIAHI96759990073460501(C)(5)$10,000GENERAL SUPPORT
HAWAII LODGING & TOURISM ASSOCIATION
2270 KALAKAUA AVE SUITE 1702HONOLULUHI96815990078248501(C)(6)$20,000GENERAL SUPPORT
HEALTHYWOMEN
1 HARDING RD SUITE 101 PO BOX 430RED BANKNJ07701521624846501(C)(3)$10,000SPONSORSHIP
HUDSON INSTITUTE INC
1201 PENNSYLVANIA AVE NW SUITE 400WASHINGTONDC20004131945157501(C)(3)$85,000GENERAL SUPPORT
INSTITUTE FOR PATIENT ACCESS
PO BOX 670BETTENDORFIA52722453456087501(C)(3)$30,000DONATION
IOWA BIOTECHNOLOGY ASSOCIATION
900 E DES MOINES STDES MOINESIA50309319885797501(C)(6)$10,000GENERAL SUPPORT
JDRF INTERNATIONAL
26 BROADWAY 15TH FLOORNEW YORKNY10004231907729501(C)(3)$10,000SPONSORSHIP
KEYSTONE POLICY CENTER
1628 SAINTS JOHN ROADKEYSTONECO80435840688506501(C)(3)$20,000SPONSORSHIP
LIFE SCIENCE TENNESSEE
217 5TH AVE NORTH SUITE 200NASHVILLETN37219621776913501(C)(6)$28,500SPONSORSHIP
LIFE SCIENCES PENNSYLVANIA
650 EAST SWEDESFORD RD SUITE 190WAYNEPA19087251621500501(C)(6)$10,000SPONSORSHIP
MARYLAND TECHNOLOGY COUNCIL INC
9841 WASHINGTONIAN BLVD SUITE 200GAITHERSBURGMD20878204950778501(C)(6)$20,000GENERAL SUPPORT
MARYLAND TECHNOLOGY COUNCIL INC
9841 WASHINGTONIAN BLVD SUITE 200GAITHERSBURGMD20878204950778501(C)(6)$7,500SPONSORSHIP
MEDMATES INC
184 BURNSIDE AVENUEWOONSOCKETRI02895462858053501(C)(6)$6,000SPONSORSHIP
NATIONAL COALITION FOR CANCER SURVIVORSHIP
8455 COLESVILLE ROAD SUITE 930SILVER SPRINGMD20910850357897501(C)(3)$20,000SPONSORSHIP
NATIONAL FARMERS UNION
20 F STREET NW SUITE300WASHINGTONDC20001840200555501(C)(3)$10,000SPONSORSHIP
NATIONAL PSORIASIS FOUNDATION
6600 SW 92ND AVE SUITE 300PORTLANDOR97223930571472501(C)(3)$15,000GENERAL SUPPORT
NEHI INC
133 FEDERAL STREET 9TH FLOORBOSTONMA02110010624865501(C)(3)$25,000GENERAL SUPPORT
NEHI INC
133 FEDERAL STREET 9TH FLOORBOSTONMA02110010624865501(C)(3)$25,000GENERAL SUPPORT
NO LABELS
1130 CONNECTICUT AVE NW SUITE 325WASHINGTONDC20036271432208501(C)(4)$15,000CONTRIBUTION
OREGON BIOSCIENCE ASSOCIATION
2828 SW CORBETT AVE SUITE 115PORTLANDOR97201931009329501(C)(5)$10,000SPONSORSHIP
PARTNERSHIP FOR AMERICA'S HEALTH CARE FUTURE INC
PO BOX 65492WASHINGTONDC200355492830939222N/A$300,000DONATION
PERSONALIZED MEDICINE COALITION
1710 RHODE ISLAND AVE NWWASHINGTONDC20036542134884501(C)(3)$10,000SPONSORSHIP
PHRMA
950 F STREET NW SUITE 300WASHINGTONDC20004530241211501(C)(6)$40,000SPONSORSHIP
PREVENT CANCER FOUNDATION
1600 DUKE STREET SUITE 500ALEXANDRIAVA22314521429544501(C)(3)$7,000SPONSORSHIP
REPUBLICAN GOVERNORS ASSOCIATION
1747 PENNSYLVANIA AVE NW SUITE 250WASHINGTONDC20006113655877N/A$100,000GENERAL SUPPORT
SOCIETY FOR WOMEN'S HEALTH RESEARCH
1025 CONNECTICUT AVE NW SUITE 601WASHINGTONDC20036521694732501(C)(3)$15,000SPONSORSHIP
TEXAS HEALTHCARE AND BIOSCIENCE INSTITUTE
815 BRAZOS ST SUITE 310AUSTINTX78701760501034501(C)(6)$25,000GENERAL SUPPORT
THE CONGRESSIONAL HUNGER CENTER
WEWORK APOLLO BUILDING 810 7TH STWASHINGTONDC20002521842738501(C)(3)$5,000SPONSORSHIPNE SUITE 02-146
THE GALIEN FOUNDATION INC
99 JOHN STREET SUITE 2502NEW YORKNY10038264549935501(C)(3)$15,000SPONSORSHIP
THE LEUKEMIA & LYMPHOMA SOCIETY NATIONAL CAPITAL AREA CHAPTER
3601 EISENHOWER AVENUE SUITE 450ALEXANDRIAVA22304135644916501(C)(3)$10,000SPONSORSHIP
THE UNITED STATES ASSOCIATION OF FORMER MEMBERS OF CONGRESS
1401 K STREET NW SUITE 503WASHINGTONDC20005540883744501(C)(3)$25,000SPONSORSHIP
THORN RUN PARTNERS LLC
100 M STREET SE SUITE 750WASHINGTONDC20003271541515N/A$140,000GENERAL SUPPORT
WASHINGTON INTERNATIONAL TRADE FOUNDATION
1300 PENNSYLVANIA AVE NW SUITE 400WASHINGTONDC20004521907420501(C)(3)$9,000CONTRIBUTION
WASHINGTON LEGAL FOUNDATION
2009 MASSACHUSETTS AVE NWWASHINGTONDC20036521071570501(C)(3)$10,000GENERAL SUPPORT
FieldValueIRS element (for citing)
Total501c3 Org36Total501c3OrgCnt
Total Other Org43TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationBIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE GRANT RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGEMENTS RELATED TO THE FUNDS GRANTED.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Travel For CompanionsYes (X)TravelForCompanionsInd
Written Policy Ref T And E Expnss0WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (1)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (1)SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
JAMES GREENWOOD
PRESIDENT & CHIEF EXECUTIVE OFFICER$1,563,303$0$1,015,560$0$0$0$36,500$0$113,727$0$2,729,090$0$0$0
YVETTE WHITE-WIGGINS
SVP & CHIEF FINANCIAL OFFICER$323,667$0$101,970$0$0$0$36,500$0$35,378$0$497,515$0$0$0
THOMAS DILENGE
PRESIDENT, ADVOCACY/LAW/PUBLIC POLIC$484,674$0$222,614$0$0$0$36,500$0$36,013$0$779,801$0$0$0
JOANNE DUNCAN
PRESIDENT, MEMBERSHIP & BUS OPER DIV$484,674$0$222,614$0$0$0$36,500$0$31,359$0$775,147$0$0$0
DANIEL DURHAM
EVP, HEALTH POLICY$459,654$0$142,800$0$0$0$36,500$0$33,768$0$672,722$0$0$0
BRENT ERICKSON
EVP, INDUSTRIAL & ENVIRONMENT$398,000$0$101,970$0$18,012$0$36,500$0$19,618$0$574,100$0$0$0
JOSEPH DAMOND
SVP, INTERNATIONAL AFFAIRS$373,858$0$112,339$0$0$0$36,500$0$36,568$0$559,265$0$0$0
JEANNE HAGGERTY
EVP, GOVERMENT AFFAIRS & EXTERNAL RE$350,000$0$113,344$0$17,917$0$33,794$0$13,159$0$528,214$0$0$0
ELIZABETH ESHAM
EVP, ECS & VP, SCIENCE & REGULATORY$350,000$0$111,023$0$0$0$36,500$0$15,284$0$512,807$0$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 1AINCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL -TRAVEL FOR COMPANIONS - $8,016
PART I, LINE 1BTHE CHIEF EXECUTIVE OFFICER HAS A PREPAID SPENDING ACCOUNT AT A LOCAL RESTAURANT, USED EXCLUSIVELY FOR BUSINESS PURPOSES.
PART I, LINE 4BJAMES GREENWOOD - 457(F) $741,468

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (2 entries)

Relationship DescriptionRelationshipDescriptionTxtTransactionTransactionAmtTransactionTransactionDescSharing Of RevenuesSharingOfRevenuesInd
LAURA GREENWOOD
DAUGHTER OF CEO$76,724PAID EMPLOYEE OF ORGANIZATION0
LILY DOEFLER
DAUGHTER OF A BOARD MEMBER$50,981PAID EMPLOYEE OF ORGANIZATION0

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 1THE BOARD OF DIRECTORS SHALL DESIGNATE BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION; THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION.
FORM 990, PART VI, SECTION A, LINE 6THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS: ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS: ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER.
FORM 990, PART VI, SECTION A, LINE 7AAT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CHIEF FINANCIAL OFFICER (CFO). THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, DIVISION PRESIDENTS, CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD AND BIO EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CBIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH DIRECTOR ON ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE.
FORM 990, PART VI, SECTION B, LINE 15FOR 2018, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO) OF BIO WAS COMPENSATED PER THE TERMS OF A MULTI-YEAR CONTRACT THAT WAS DETERMINED WITH INDEPENDENT REVIEW, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION AS INDICATED IN PRIOR FORM 990 SUBMISSIONS. IN ADDITION, BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2018, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH THE RELEVANT PROVISION OF THE EXECUTIVE AGREEMENT. DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE PRESIDENTS OF THE TWO DIVISIONS AT BIO LED THE PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.
FORM 990, PART IX, LINE 11GEC EMERGING PRIORITIES 6,859,539. WORKPLAN OBJECTIVES 79,775. I&E INITIATIVES 35,242. INTERNS 45,728. TEMPORARY HELP 159,530. CEO DELEGATION EXPENSE 17,187. ECONOMIC STUDIES 360,174. CONSULTANTS AND OTHER PROFESSIONAL FEES 1,493,584. BIO-PAC ADMINISTRATIVE 27,437. BUSINESS DEVELOPMENT EXEC PRESENTATION 43,875. PROGRAM INITIATIVES 66,388. RECRUITMENT 125,069. BUSINESS STRATEGIES 9,613. EDUCATION 67,954.
FORM 990, PART XI, LINE 9:DEFERRED SPONSORSHIP EXPENSE 40,000. NET EXCLUSIVE BUSINESS SOLUTION 619,350.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1EXCELLENCE THROUGH STEWARDSHIPBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVE SW SUITE 900AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd
FieldValueIRS element (for citing)
EIN263021330EIN
Primary ActivitiesTO PROMOTE THE RESPONSIBLE USE OF AGRICULTURAL BIOTECHNOLOGYPrimaryActivitiesTxt
Legal Domicile StateDCLegalDomicileStateCd
Exempt Code Section501(C)(4)ExemptCodeSectionTxt
Controlled Organization0ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgYes (1)PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd